Rational Advisors LLC United Therapeutics Corp Transaction History

Rational Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$101.87 - $151.79 $6,010 - $8,955	-59 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$99.9 - $121.13 $3,996 - $4,845	40 Added 210.53%	59 $6,000
Q2 2020 Aug 10, 2020	BUY	$92.74 - $125.82 $1,762 - $2,390	19 New	19 $2,000
Q1 2020 May 12, 2020	SELL	$79.39 - $115.35 $7,859 - $11,419	-99 Closed	0 $0
Q3 2019 Nov 06, 2019	SELL	$74.85 - $85.99 $10,778 - $12,382	-144 Reduced 59.26%	99 $8,000
Q2 2019 Aug 08, 2019	BUY	$76.06 - $120.81 $18,178 - $28,873	239 Added 5975.0%	243 $19,000
Q1 2019 May 08, 2019	SELL	$107.15 - $126.84 $321 - $380	-3 Reduced 42.86%	4 $0
Q2 2018 Aug 07, 2018	SELL	$101.14 - $118.31 $1,415 - $1,656	-14 Reduced 66.67%	7 $1,000
Q1 2018 May 18, 2018	BUY	$107.21 - $151.94 $2,251 - $3,190	21 New	21 $2,000

672

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Rational Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Rational Advisors LLC with notifications on news.